Christopher A. Jedeszko, Ph.D.
Affiliations: | 2009 | Pharmacology | Wayne State University, Detroit, MI, United States |
Area:
Cell BiologyGoogle:
"Christopher Jedeszko"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Bonnie F. Sloane | grad student | 2009 | Wayne State | |
| (Three-dimensional organotypic cultures of ductal carcinoma in situ model the effects of stroma on breast cancer progression.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jedeszko C, Paez-Ribes M, Di Desidero T, et al. (2015) Postsurgical adjuvant or metastatic renal cell carcinoma therapy models reveal potent antitumor activity of metronomic oral topotecan with pazopanib. Science Translational Medicine. 7: 282ra50 |
| Ebos JM, Mastri M, Lee CR, et al. (2014) Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy. Embo Molecular Medicine. 6: 1561-76 |
| Di Matteo P, Hackl C, Jedeszko C, et al. (2013) NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cells. British Journal of Cancer. 109: 360-9 |
| Caglič D, Repnik U, Jedeszko C, et al. (2013) The proinflammatory cytokines interleukin-1α and tumor necrosis factor α promote the expression and secretion of proteolytically active cathepsin S from human chondrocytes. Biological Chemistry. 394: 307-16 |
| Matteo PD, Hackl C, Jedeszko C, et al. (2012) Abstract 4381: The novel direct-acting vascular targeting agent NGR-TNF exertsin vivoantitumor activity by inducing endothelial and tumor cell death in the absence of proangiogenic bone-marrow derived cell recruitment Cancer Research. 72: 4381-4381 |
| Ebos JML, Lee CR, Cruz-Munoz W, et al. (2012) Abstract 1375: Contrasting effects of VEGF pathway inhibitors in primary and metastatic disease using perioperative neoadjuvant mouse models Cancer Research. 72: 1375-1375 |
| Matteo PD, Hackl C, Jedeszko C, et al. (2011) Abstract 4249: NGR-TNF, a novel direct-acting vascular targeting agent, does not induce “cytokine-rebound” recruitment of pro-angiogenic bone-marrow derived cells Cancer Research. 71: 4249-4249 |
| Jedeszko C, Victor BC, Podgorski I, et al. (2009) Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ. Cancer Research. 69: 9148-55 |
| Sameni M, Cavallo-Medved D, Dosescu J, et al. (2009) Imaging and quantifying the dynamics of tumor-associated proteolysis Clinical and Experimental Metastasis. 26: 299-309 |
| Jedeszko C, Sameni M, Olive MB, et al. (2008) Visualizing protease activity in living cells: from two dimensions to four dimensions. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. Unit 4.20 |